[Comparative analysis of antioxidant activity of nebivolol in patients with chronic heart failure with and without concomitant type 2 diabetes].

MLA

Belenkov, Iu N., et al. “[Comparative Analysis of Antioxidant Activity of Nebivolol in Patients with Chronic Heart Failure with and without Concomitant Type 2 Diabetes].” Kardiologiia, vol. 51, no. 1, 2011, pp. 5–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21626795&authtype=sso&custid=ns315887.

APA

Belenkov, I. N., Privalova, E. V., Chekneva, I. S., Zheleznych, E. A., Khiazeva, L. V., Azizova, O. A., Aseĭchev, A. V., Baranova, O. A., & Shvachko, A. G. (2011). [Comparative analysis of antioxidant activity of nebivolol in patients with chronic heart failure with and without concomitant type 2 diabetes]. Kardiologiia, 51(1), 5–10.

Chicago

Belenkov, Iu N, E V Privalova, I S Chekneva, E A Zheleznych, L V Khiazeva, O A Azizova, A V Aseĭchev, O A Baranova, and A G Shvachko. 2011. “[Comparative Analysis of Antioxidant Activity of Nebivolol in Patients with Chronic Heart Failure with and without Concomitant Type 2 Diabetes].” Kardiologiia 51 (1): 5–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21626795&authtype=sso&custid=ns315887.